EBITDA Summary of Pro Medicus Limited

Pro Medicus Limited's latest annual EBITDA in 2024 was 120.76 Million AUD , up 28.4% from previous year.
Pro Medicus Limited's latest quarterly EBITDA in 2024 FY was N/A , up 31.55% from previous quarter.
Pro Medicus Limited reported an annual EBITDA of 94.05 Million AUD in 2023, up 31.7% from previous year.
Pro Medicus Limited reported an annual EBITDA of 70.39 Million AUD in 2022, up 40.59% from previous year.
Pro Medicus Limited reported a quarterly EBITDA of N/A for 2024 FY, up 31.55% from previous quarter.
Pro Medicus Limited reported a quarterly EBITDA of 67.42 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Pro Medicus Limited (2024 - 1999)

Historical Annual EBITDA of Pro Medicus Limited (2024 - 1999)

Year	EBITDA	EBITDA Growth
2024	120.76 Million AUD	28.4%
2023	94.05 Million AUD	31.7%
2022	70.39 Million AUD	40.59%
2021	50.07 Million AUD	31.34%
2020	37.74 Million AUD	47.12%
2019	31.52 Million AUD	71.84%
2018	21.75 Million AUD	4.08%
2017	18.41 Million AUD	47.73%
2016	13.32 Million AUD	175.18%
2015	3.52 Million AUD	29.6%
2014	2.72 Million AUD	-57.05%
2013	1.74 Million AUD	106.04%
2012	3.07 Million AUD	-28.36%
2011	4.29 Million AUD	-44.32%
2010	7.71 Million AUD	269.09%
2009	2.09 Million AUD	-62.7%
2008	5.6 Million AUD	-38.83%
2007	9.15 Million AUD	14.34%
2006	8.01 Million AUD	2.88%
2005	7.78 Million AUD	52.37%
2004	5.11 Million AUD	-21.77%
2003	6.53 Million AUD	-5.13%
2002	6.88 Million AUD	9.84%
2001	6.26 Million AUD	20.93%
2000	5.18 Million AUD	161.9%
1999	1.97 Million AUD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	53.33 Million AUD	0.0%
2024 FY	- AUD	31.55%
2024 Q4	67.42 Million AUD	0.0%
2023 Q2	41.1 Million AUD	0.0%
2023 Q4	50.69 Million AUD	0.0%
2023 FY	- AUD	31.7%
2022 Q4	37.52 Million AUD	0.0%
2022 Q2	32.17 Million AUD	0.0%
2022 FY	- AUD	40.59%
2021 FY	- AUD	31.34%
2021 Q2	22.33 Million AUD	0.0%
2021 Q4	27.24 Million AUD	0.0%
2020 Q2	18.57 Million AUD	0.0%
2020 Q4	19.17 Million AUD	0.0%
2020 FY	- AUD	47.12%
2019 FY	- AUD	71.84%
2019 Q4	15.79 Million AUD	0.0%
2019 Q2	12.81 Million AUD	0.0%
2018 Q4	6.63 Million AUD	0.0%
2018 FY	- AUD	4.08%
2018 Q2	8.3 Million AUD	0.0%
2017 Q2	7.94 Million AUD	0.0%
2017 FY	- AUD	47.73%
2017 Q4	6.4 Million AUD	0.0%
2016 FY	- AUD	175.18%
2016 Q4	3.38 Million AUD	0.0%
2016 Q2	6.32 Million AUD	0.0%
2015 Q4	319 Thousand AUD	0.0%
2015 FY	- AUD	29.6%
2015 Q2	3.21 Million AUD	0.0%
2014 Q4	1.08 Million AUD	0.0%
2014 FY	- AUD	-57.05%
2014 Q2	1.63 Million AUD	0.0%
2013 Q2	1.66 Million AUD	33.35%
2013 Q1	1.24 Million AUD	0.0%
2013 Q4	1.66 Million AUD	0.0%
2013 Q3	1.66 Million AUD	0.0%
2013 FY	- AUD	106.04%
2012 Q3	1.24 Million AUD	0.0%
2012 Q2	1.24 Million AUD	34.94%
2012 Q1	924.5 Thousand AUD	0.0%
2012 FY	- AUD	-28.36%
2012 Q4	1.24 Million AUD	0.0%
2011 Q3	924.5 Thousand AUD	0.0%
2011 Q4	924.5 Thousand AUD	0.0%
2011 FY	- AUD	-44.32%
2011 Q1	2.09 Million AUD	0.0%
2011 Q2	924.5 Thousand AUD	-55.89%
2010 Q3	2.09 Million AUD	0.0%
2010 FY	- AUD	269.09%
2010 Q1	2.29 Million AUD	0.0%
2010 Q2	2.09 Million AUD	-8.74%
2010 Q4	2.09 Million AUD	0.0%
2009 Q3	2.29 Million AUD	0.0%
2009 Q1	2.96 Million AUD	0.0%
2009 Q2	2.29 Million AUD	-22.49%
2009 FY	- AUD	-62.7%
2009 Q4	2.29 Million AUD	0.0%
2008 FY	- AUD	-38.83%
2008 Q1	2.45 Million AUD	0.0%
2008 Q4	2.96 Million AUD	0.0%
2008 Q2	2.96 Million AUD	20.84%
2008 Q3	2.96 Million AUD	0.0%
2007 Q3	2.45 Million AUD	0.0%
2007 Q2	2.45 Million AUD	12.83%
2007 FY	- AUD	14.34%
2007 Q4	2.45 Million AUD	0.0%
2007 Q1	2.17 Million AUD	0.0%
2006 Q2	2.17 Million AUD	-34.54%
2006 Q3	2.17 Million AUD	0.0%
2006 FY	- AUD	2.88%
2006 Q4	2.17 Million AUD	0.0%
2006 Q1	3.31 Million AUD	0.0%
2005 Q2	3.31 Million AUD	188.17%
2005 FY	- AUD	52.37%
2005 Q3	3.31 Million AUD	0.0%
2005 Q4	3.31 Million AUD	0.0%
2005 Q1	1.15 Million AUD	0.0%
2004 Q1	2.76 Million AUD	0.0%
2004 FY	- AUD	-21.77%
2004 Q4	1.15 Million AUD	0.0%
2004 Q3	1.15 Million AUD	0.0%
2004 Q2	1.15 Million AUD	-58.4%
2003 Q4	2.76 Million AUD	0.0%
2003 Q3	2.76 Million AUD	0.0%
2003 FY	- AUD	-5.13%
2003 Q2	2.76 Million AUD	-5.29%
2003 Q1	2.92 Million AUD	0.0%
2002 Q1	2.62 Million AUD	0.0%
2002 Q2	2.92 Million AUD	11.35%
2002 Q3	2.92 Million AUD	0.0%
2002 FY	- AUD	9.84%
2002 Q4	2.92 Million AUD	0.0%
2001 Q3	2.62 Million AUD	0.0%
2001 FY	- AUD	20.93%
2001 Q1	2.11 Million AUD	0.0%
2001 Q4	2.62 Million AUD	0.0%
2001 Q2	2.62 Million AUD	23.97%
2000 Q4	2.11 Million AUD	0.0%
2000 Q1	805.25 Thousand AUD	0.0%
2000 Q2	2.11 Million AUD	163.09%
2000 Q3	2.11 Million AUD	0.0%
2000 FY	- AUD	161.9%
1999 FY	- AUD	0.0%
1999 Q4	805.25 Thousand AUD	0.0%
1999 Q3	805.25 Thousand AUD	0.0%
1999 Q2	805.25 Thousand AUD	0.0%

Peer EBITDA Comparison of Pro Medicus Limited

Name	EBITDA	EBITDA Difference
Alcidion Group Limited	-4.49 Million AUD	2785.988%
Artrya Limited	-13.95 Million AUD	965.367%
Beamtree Holdings Limited	-331 Thousand AUD	36583.988%
Cogstate Limited	9.89 Million AUD	-1120.893%
Careteq Limited	-826.61 Thousand AUD	14709.202%
Doctor Care Anywhere Group PLC	-8.35 Million AUD	1545.559%
Emyria Limited	-13.03 Million AUD	1026.455%
Global Health Limited	-1.76 Million AUD	6939.037%
HITIQ Limited	-2.54 Million AUD	4849.508%
Intelicare Holdings Limited	-3.02 Million AUD	4098.053%
ImExHS Limited	-1.25 Million AUD	9701.653%
Mach7 Technologies Limited	-2.44 Million AUD	5045.128%
MedAdvisor Limited	7.04 Million AUD	-1613.348%
Oakridge International Limited	-630.05 Thousand AUD	19266.959%
Opyl Limited	-3.2 Million AUD	3862.936%
PainChek Limited	-9.48 Million AUD	1372.72%
Resonance Health Limited	-457 Thousand AUD	26524.483%
Singular Health Group Ltd	-2.88 Million AUD	4285.662%
Total Brain Limited	-5.49 Million AUD	2299.222%

Global Stocks Search

Pro Medicus Limited (PME.AX)

EBITDA Summary of Pro Medicus Limited

Annual EBITDA Chart of Pro Medicus Limited (2024 - 1999)

Historical Annual EBITDA of Pro Medicus Limited (2024 - 1999)

Peer EBITDA Comparison of Pro Medicus Limited